Prion Infections and Anti-PrP Antibodies Trigger Converging Neurotoxic Pathways

English version České info

Prion diseases are a group of infectious, invariably fatal neurodegenerative diseases. Progress in developing therapeutics is slow, partly because animal models of prion diseases require stringent biosafety and are very slow. We recently found that treatment of cerebellar slices with antibodies targeting the globular domain (GD ligands) of the prion protein (PrP) is neurotoxic. Here we compared this model to prion infection, and describe striking similarities. Both models involved the production of reactive oxygen species, and antioxidants could reverse the toxicity in cerebellar slices and even prolong the survival time of prion-infected mice. Antibodies targeting the flexible tail of PrP that prevent toxicity of GD ligands reduced the toxicity induced by prions. Endoplasmic reticulum stress, which is involved in prion toxicity, is also found in GD-ligand induced neurotoxicity. Finally, changes of gene expression were similar in both models. We conclude that prion infection and GD ligands use converging neurotoxic pathways. Because GD ligands induce toxicity within days rather than months and do not pose biosafety hazards, they may represent a powerful tool for furthering our understanding of prion pathogenesis and also for the discovery of antiprion drugs.

Vyšlo v časopise: Prion Infections and Anti-PrP Antibodies Trigger Converging Neurotoxic Pathways. PLoS Pathog 11(2): e32767. doi:10.1371/journal.ppat.1004662
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004662

Souhrn

Zdroje

1. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216 : 136–144. 6801762

2. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 : 339–343. 8552188

3. Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Muller V, et al. (2011) The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. Embo J 30 : 2057–2070. doi: 10.1038/emboj.2011.86 21441896

4. Soto C, Satani N (2010) The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med.

5. Torres M, Castillo K, Armisen R, Stutzin A, Soto C, et al. (2010) Prion protein misfolding affects calcium homeostasis and sensitizes cells to endoplasmic reticulum stress. PLoS ONE 5: e15658. doi: 10.1371/journal.pone.0015658 21209925

6. Steele AD, Hetz C, Yi CH, Jackson WS, Borkowski AW, et al. (2007) Prion pathogenesis is independent of caspase-12. Prion 1 : 243–247. 19164919

7. Steele AD, King OD, Jackson WS, Hetz CA, Borkowski AW, et al. (2007) Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo. J Neurosci 27 : 13022–13027. 18032675

8. Aguib Y, Heiseke A, Gilch S, Riemer C, Baier M, et al. (2009) Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 5 : 361–369. 19182537

9. Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, et al. (2012) Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485 : 507–511. doi: 10.1038/nature11058 22622579

10. Moreno JA, Halliday M, Molloy C, Radford H, Verity N, et al. (2013) Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med 5 : 206ra138. doi: 10.1126/scitranslmed.3006767 24107777

11. Falsig J, Aguzzi A (2008) The prion organotypic slice culture assay—POSCA. Nat Protoc 3 : 555–562. doi: 10.1038/nprot.2008.13 18388937

12. Falsig J, Julius C, Margalith I, Schwarz P, Heppner F, et al. (2008) A versatile prion replication assay in organotypic brain slices. Nat Neurosci 11 : 109–117. 18066056

13. Falsig J, Sonati T, Herrmann US, Saban D, Li B, et al. (2012) Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. PLoS Pathog 8: e1002985. doi: 10.1371/journal.ppat.1002985 23133383

14. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, et al. (2008) The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 3: e3872. doi: 10.1371/journal.pone.0003872 19060956

15. Sonati T, Reimann RR, Falsig J, Baral PK, O'Connor T, et al. (2013) The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 501 : 102–106. doi: 10.1038/nature12402 23903654

16. Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, et al. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15 : 1255–1264. 8635458

17. Brennan AM, Suh S.W., Won S.J., Narasimhan P., Kauppinen T.M., Lee H., Edling Y., Chan P.H., Swanson R.A. (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 12 : 857–863. doi: 10.1038/nn.2334 19503084

18. Maghzal GJ, Krause KH, Stocker R, Jaquet V (2012) Detection of reactive oxygen species derived from the family of NOX NADPH oxidases. Free Radic Biol Med 53 : 1903–1918. doi: 10.1016/j.freeradbiomed.2012.09.002 22982596

19. Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa MC (2010) Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev 68 : 191–206. doi: 10.1111/j.1753-4887.2010.00278.x 20416016

20. Fuhrmann M, Bittner T, Mitteregger G, Haider N, Moosmang S, et al. (2006) Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons. J Neurochem 98 : 1876–1885. 16945105

21. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, et al. (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 181 : 551–565. doi: 10.1083/jcb.200711002 18443219

22. Klohn PC, Stoltze L, Flechsig E, Enari M, Weissmann C (2003) A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci U S A 100 : 11666–11671. 14504404

23. Mahal SP, Demczyk CA, Smith EW Jr., Klohn PC, Weissmann C (2008) Assaying prions in cell culture: the standard scrapie cell assay (SSCA) and the scrapie cell assay in end point format (SCEPA). Methods Mol Biol 459 : 49–68. doi: 10.1007/978-1-59745-234-2_4 18576147

24. Jindal E, Goswami SK (2011) In cardiac myoblasts, cellular redox regulates FosB and Fra-1 through multiple cis-regulatory modules. Free Radic Biol Med 51 : 1512–1521. doi: 10.1016/j.freeradbiomed.2011.07.008 21820506

25. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102 : 15545–15550. 16199517

26. Lee HP, Jun YC, Choi JK, Kim JI, Carp RI, et al. (2005) Activation of mitogen-activated protein kinases in hamster brains infected with 263K scrapie agent. J Neurochem 95 : 584–593. 16135077

27. Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, et al. (2013) PDK1 decreases TACE-mediated alpha-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med 19 : 1124–1131. doi: 10.1038/nm.3302 23955714

28. Yao H, Zhao D, Khan SH, Yang L (2013) Role of autophagy in prion protein-induced neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai) 45 : 494–502. doi: 10.1093/abbs/gmt022 23459558

29. Tribouillard-Tanvier D, Race B, Striebel JF, Carroll JA, Phillips K, et al. (2012) Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35. J Virol 86 : 10377–10383. doi: 10.1128/JVI.01340-12 22787236

30. Kordek R, Nerurkar VR, Liberski PP, Isaacson S, Yanagihara R, et al. (1996) Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc Natl Acad Sci U S A 93 : 9754–9758. 8790403

31. Baral PK, Wieland B, Swayampakula M, Polymenidou M, Rahman MH, et al. (2012) Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1. Acta Crystallogr D Biol Crystallogr 68 : 1501–1512. doi: 10.1107/S0907444912037328 23090399

32. Baral PK, Wieland B, Swayampakula M, Polymenidou M, Aguzzi A, et al. (2011) Crystallization and preliminary X-ray diffraction analysis of prion protein bound to the Fab fragment of the POM1 antibody. Acta Crystallogr Sect F Struct Biol Cryst Commun 67 : 1211–1213. doi: 10.1107/S1744309111026273 22102029

33. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, et al. (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303 : 1514–1516. 14752167

34. Büeler HR, Fischer M, Lang Y, Bluethmann H, Lipp HP, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 : 577–582. 1373228

35. Falsig J ST, Herrmann US, Saban D, Li B, Arroyo K, Ballmer B, Liberski PP, Aguzzi A (2012) Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. plos pathogens.

36. Murakami K, Kondo T, Kawase M, Li Y, Sato S, et al. (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18 : 205–213. 9412501

37. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 : 249–264. 12925520

38. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, et al. (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26 : 317–325. doi: 10.1038/nbt1385 18278033